Cogent Biosciences price target raised to $15 from $13 at Citi
PremiumThe FlyCogent Biosciences price target raised to $15 from $13 at Citi
1M ago
Cogent Biosciences price target raised to $10 from $8 at Baird
Premium
The Fly
Cogent Biosciences price target raised to $10 from $8 at Baird
2M ago
Cogent Biosciences price target lowered to $17 from $19 at H.C. Wainwright
Premium
The Fly
Cogent Biosciences price target lowered to $17 from $19 at H.C. Wainwright
2M ago
Cogent Biosciences reports Q2 EPS (59c), consensus (56c)
PremiumThe FlyCogent Biosciences reports Q2 EPS (59c), consensus (56c)
3M ago
Cogent Biosciences announces FDA meeting, alignment of MS2D2
Premium
The Fly
Cogent Biosciences announces FDA meeting, alignment of MS2D2
4M ago
Cogent Biosciences announces clinical data from Part 1 of ongoing SUMMIT trial
Premium
The Fly
Cogent Biosciences announces clinical data from Part 1 of ongoing SUMMIT trial
5M ago
Cogent Biosciences files to sell 31.2M shares of common stock for holders
PremiumThe FlyCogent Biosciences files to sell 31.2M shares of common stock for holders
7M ago
Cogent Biosciences price target raised to $19 from $13 at H.C. Wainwright
Premium
The Fly
Cogent Biosciences price target raised to $19 from $13 at H.C. Wainwright
8M ago
Cogent Biosciences expects cash to fund requirements into 2027
Premium
The Fly
Cogent Biosciences expects cash to fund requirements into 2027
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100